Clinical Trials · NCT03741517

Biomarker Study of Pancreatic Neuroendocrine Tumours

UnknownN/AOctreotide (Unclear)
Phase
N/A
Recruitment status
Unknown
Sponsor
Uppsala University
Enrollment
40
Start date
Jan 2019
Locations
1 site, Sweden
Primary endpoint
Protocol adherence
View Octreotide compound reference